Abstract

Angiolipomas, a variant of a typical lipoma, are not uncommon benign neoplasms composed of adipocytes admixed with abnormal angiomatous elements. The detection of angiolipomas by fluorodeoxyglucose (FDG) positron emission tomography (PET) has not been previously reported. A subcutaneous angiolipoma with intermediate increased accumulation of FDG was visible on a whole-body PET study. It is likely that hypervascularity, blood pooling in vascular structures with congested lumens, and accelerated inflammatory processes account for the imaging findings. This became evident during image interpretation and in determining whether the tumor was benign or malignant.

Original languageEnglish
Pages (from-to)604-605
Number of pages2
JournalClinical Nuclear Medicine
Volume28
Issue number7
DOIs
Publication statusPublished - Jul 2003

Fingerprint

Angiolipoma
Fluorodeoxyglucose F18
Positron-Emission Tomography
Lipoma
Adipocytes
Blood Vessels
Neoplasms

Keywords

  • Angiolipoma
  • Positron emission tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Angiolipoma Detected by F-18 FDG Positron Emission Tomography. / Hsu, Chung-Huei; Yang, Che-Ming; Cheng, Chien-Jui.

In: Clinical Nuclear Medicine, Vol. 28, No. 7, 07.2003, p. 604-605.

Research output: Contribution to journalArticle

@article{53bd12af6c24461aa0b7633d99f5e02c,
title = "Angiolipoma Detected by F-18 FDG Positron Emission Tomography",
abstract = "Angiolipomas, a variant of a typical lipoma, are not uncommon benign neoplasms composed of adipocytes admixed with abnormal angiomatous elements. The detection of angiolipomas by fluorodeoxyglucose (FDG) positron emission tomography (PET) has not been previously reported. A subcutaneous angiolipoma with intermediate increased accumulation of FDG was visible on a whole-body PET study. It is likely that hypervascularity, blood pooling in vascular structures with congested lumens, and accelerated inflammatory processes account for the imaging findings. This became evident during image interpretation and in determining whether the tumor was benign or malignant.",
keywords = "Angiolipoma, Positron emission tomography",
author = "Chung-Huei Hsu and Che-Ming Yang and Chien-Jui Cheng",
year = "2003",
month = "7",
doi = "10.1097/00003072-200307000-00020",
language = "English",
volume = "28",
pages = "604--605",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Angiolipoma Detected by F-18 FDG Positron Emission Tomography

AU - Hsu, Chung-Huei

AU - Yang, Che-Ming

AU - Cheng, Chien-Jui

PY - 2003/7

Y1 - 2003/7

N2 - Angiolipomas, a variant of a typical lipoma, are not uncommon benign neoplasms composed of adipocytes admixed with abnormal angiomatous elements. The detection of angiolipomas by fluorodeoxyglucose (FDG) positron emission tomography (PET) has not been previously reported. A subcutaneous angiolipoma with intermediate increased accumulation of FDG was visible on a whole-body PET study. It is likely that hypervascularity, blood pooling in vascular structures with congested lumens, and accelerated inflammatory processes account for the imaging findings. This became evident during image interpretation and in determining whether the tumor was benign or malignant.

AB - Angiolipomas, a variant of a typical lipoma, are not uncommon benign neoplasms composed of adipocytes admixed with abnormal angiomatous elements. The detection of angiolipomas by fluorodeoxyglucose (FDG) positron emission tomography (PET) has not been previously reported. A subcutaneous angiolipoma with intermediate increased accumulation of FDG was visible on a whole-body PET study. It is likely that hypervascularity, blood pooling in vascular structures with congested lumens, and accelerated inflammatory processes account for the imaging findings. This became evident during image interpretation and in determining whether the tumor was benign or malignant.

KW - Angiolipoma

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=0141610867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141610867&partnerID=8YFLogxK

U2 - 10.1097/00003072-200307000-00020

DO - 10.1097/00003072-200307000-00020

M3 - Article

C2 - 12819423

VL - 28

SP - 604

EP - 605

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 7

ER -